Skinvisible (OTCMKTS:SKVI) Issues Quarterly Earnings Results

Skinvisible (OTCMKTS:SKVIGet Free Report) released its quarterly earnings results on Thursday. The company reported ($0.05) EPS for the quarter, Zacks reports.

Skinvisible Price Performance

Shares of SKVI stock remained flat at $0.18 during mid-day trading on Thursday. The company’s stock had a trading volume of 1 shares, compared to its average volume of 467. Skinvisible has a 12 month low of $0.08 and a 12 month high of $0.90. The firm’s 50-day moving average price is $0.21 and its two-hundred day moving average price is $0.26. The company has a market capitalization of $972,000.00, a PE ratio of -0.90 and a beta of 1.79.

About Skinvisible

(Get Free Report)

Skinvisible, Inc, together with its subsidiaries, focuses on the development, manufacture, and sale of topical, transdermal, and mucosal polymer-based delivery system technologies and formulations for use in pharmaceutical, over-the-counter, personal skincare, and cosmetic arenas. Its non-dermatological formulations offer solutions for women's health, pain management, and other markets. The company's flagship product is Invisicare, a patented polymer delivery system technology that enhances the delivery of active ingredients for topically applied skin care products.

Read More

Earnings History for Skinvisible (OTCMKTS:SKVI)

Receive News & Ratings for Skinvisible Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Skinvisible and related companies with MarketBeat.com's FREE daily email newsletter.